XML 100 R88.htm IDEA: XBRL DOCUMENT v3.25.1
SEGMENT INFORMATION - Narrative (Details) - Product Concentration Risk
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenue from Contract with Customer, Segment Benchmark | Xifaxan Branded Products | Salix    
Segment reporting information    
Concentration risk percentage 85.00%  
Revenues | Customer, Top Ten Products    
Segment reporting information    
Concentration risk percentage 50.00% 48.00%